Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Characterising long term Covid-19: a living systematic review

View ORCID ProfileMelina Michelen, Vincent Cheng, View ORCID ProfileLakshmi Manoharan, View ORCID ProfileNatalie Elkheir, View ORCID ProfileDrew Dagens, View ORCID ProfileClaire Hastie, Margaret O’Hara, Jake C. Suett, Dania T. Dahmash, Polina Bugaeva, Ishmeala Rigby, Daniel Munblit, Eli Harriss, View ORCID ProfileAmanda Burls, Carol Foote, Janet T. Scott, View ORCID ProfileGail Carson, View ORCID ProfilePiero Olliaro, View ORCID ProfileLouise Sigfrid, View ORCID ProfileCharitini Stavropoulou
doi: https://doi.org/10.1101/2020.12.08.20246025
Melina Michelen
1School of Health Sciences, City, University of London, London, UK
2ISARIC Global Support Centre, Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Melina Michelen
Vincent Cheng
3Bristol Medical School, University of Bristol, Bristol, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lakshmi Manoharan
2ISARIC Global Support Centre, Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lakshmi Manoharan
Natalie Elkheir
2ISARIC Global Support Centre, Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, UK
4Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Natalie Elkheir
Drew Dagens
2ISARIC Global Support Centre, Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Drew Dagens
Claire Hastie
5Long Covid Support
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Claire Hastie
Margaret O’Hara
5Long Covid Support
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jake C. Suett
6Queen Elizabeth Hospital, Kings Lynn, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dania T. Dahmash
2ISARIC Global Support Centre, Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Polina Bugaeva
7Julius-Maximilians-Universität Würzburg, Würzburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ishmeala Rigby
2ISARIC Global Support Centre, Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Munblit
8Department of Paediatrics and Paediatric Infectious Diseases, Institute of Child’s Health, Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia
9Inflammation, Repair and Development Section, National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, United Kingdom
10Research and Clinical Center for Neuropsychiatry, Moscow, Russia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eli Harriss
12Bodleian Health Care Libraries, University of Oxford, Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amanda Burls
1School of Health Sciences, City, University of London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Amanda Burls
Carol Foote
11Freelance, Soquel, California, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Janet T. Scott
13MRC-University of Glasgow Centre for Virus Research, Glasgow, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gail Carson
2ISARIC Global Support Centre, Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Gail Carson
Piero Olliaro
2ISARIC Global Support Centre, Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Piero Olliaro
Louise Sigfrid
2ISARIC Global Support Centre, Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Louise Sigfrid
Charitini Stavropoulou
1School of Health Sciences, City, University of London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Charitini Stavropoulou
  • For correspondence: C.Stavropoulou@city.ac.uk
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background While it is now apparent clinical sequelae (often called Long Covid) may persist after acute Covid-19, their nature, frequency, and aetiology are poorly characterised. This study aims to regularly synthesise evidence on Long Covid characteristics, to inform clinical management, rehabilitation, and interventional studies to improve long term outcomes.

Methods A living systematic review. Medline, CINAHL (EBSCO), Global Health (Ovid), WHO Global Research Database on Covid-19, LitCOVID, and Google Scholar were searched up to 17th March 2021. Published studies including at least 100 people with confirmed or clinically suspected Covid-19 at 12 weeks or more post-onset were included. Results were analysed using descriptive statistics and meta-analyses to estimate prevalence with 95% confidence intervals (CIs).

Results Thirty-nine studies were included: 32 cohort, six cross-sectional, and one case-control. Most showed high or moderate risk of bias. None were set in low-income countries, limited studies included children. Studies reported on 10,951 people (48% female) in 12 countries. Most followed-up post hospital discharge (78%, 8520/10951). The longest mean follow-up was 221.7 (SD: 10.9) days post Covid-19 onset. An extensive range of symptoms with wide prevalence was reported, most commonly weakness (41%; 95% CI 25% to 59%), malaise (33%; 95% CI 15% to 57%), fatigue (31%; 95% CI 24% to 39%), concentration impairment (26%; 95% CI 21% to 32%), and breathlessness (25%; 95% CI 18% to 34%). Other frequent symptoms included musculoskeletal, neurological, and psychological. 37% (95% CI 18% to 60%) of people reported reduced quality of life.

Conclusion Long Covid is a complex condition with heterogeneous symptoms. The nature of the studies precludes a precise case definition or evaluation of risk factors. There is an urgent need for prospective, robust, standardised controlled studies into aetiology, risk factors, and biomarkers to characterise Long Covid in different at-risk populations and settings.

Systematic review registration The protocol was prospectively registered on the PROSPERO database (CRD42020211131).

Section 1: What is already known?

  • A significant number of people continue to describe ongoing symptoms long after the acute phase of Covid-19, often referred to as Long Covid.

  • Long Covid is a heterogeneous condition with an uncertain prevalence, for which there is currently no precise case definition.

Section 2: What are the new findings?

  • This ‘living’ systematic review provides a comprehensive summary of peer-reviewed published evidence on persistent symptoms of Covid-19 and will be regularly updated as new evidence emerges.

  • The breadth of reported symptoms suggests a complex, heterogeneous condition affecting both those who were hospitalised and those managed in the community.

  • Our review identifies weakness (41%; 95% CI 25% to 59%), general malaise (33%; 95% confidence interval 15% to 57%), fatigue (31%; 95% CI 24% to 39%), concentration impairment (26%; 95% CI 21% to 32%) and breathlessness (25%; 95% CI 18% to 34%) as the most common symptoms.

Section 3: What do the new findings imply?

  • The current evidence base of the clinical spectrum of Long Covid is limited, based on heterogenous data, and vulnerable to biases, hence caution should be used when interpreting or generalising the results.

  • Our review identifies areas where further Long Covid research is critically needed to help characterise Long Covid in different populations and define its aetiology, risk factors, and biomarkers, as well as the impact on variants of concern and vaccination on long term outcomes.

Competing Interest Statement

All authors have completed the ICMJE uniform disclosure form and declare: no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years. JCS declares he is an individual living with long-term symptoms of probably covid-19. All other authors declare no other relationships or activities that could appear to have influenced the submitted work.

Funding Statement

This work was supported by the UK Foreign, Commonwealth and Development Office and Wellcome [215091/Z/18/Z] and the Bill & Melinda Gates Foundation [OPP1209135]. The results presented have been obtained with the financial support of the EU FP7 project PREPARE (602525).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

No ethics approval was needed

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • ↵* Joint second authors

  • ↵** Joint senior authors

  • The revised version presents evidence up until 17th March 2021.

Data Availability

All data are available on the paper

  • List of Abbreviations

    ADL
    Activities of daily living
    AKI
    Acute kidney injury
    COVID-19
    Coronavirus Disease
    DCLO
    Diffusion capacity for carbon monoxide
    ICU
    Intensive care unit
    IQR
    Interquartile Range
    ISARIC
    International Severe Acute Respiratory and emerging Infection Consortium
    LMIC
    Low-middle income country
    LSR
    Living’ systematic review
    NICE
    National Institute for Health and Care Excellence
    NIHR
    National Institute for Health Research
    PTSD
    post traumatic stress disorder
    RoB
    Risk of bias
    SARS-CoV-2
    Severe Acute Respiratory Syndrome Coronavirus-2
    SD
    Standard deviation
    VAS
    Visual Analogue Scale
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted May 31, 2021.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Characterising long term Covid-19: a living systematic review
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Characterising long term Covid-19: a living systematic review
    Melina Michelen, Vincent Cheng, Lakshmi Manoharan, Natalie Elkheir, Drew Dagens, Claire Hastie, Margaret O’Hara, Jake C. Suett, Dania T. Dahmash, Polina Bugaeva, Ishmeala Rigby, Daniel Munblit, Eli Harriss, Amanda Burls, Carol Foote, Janet T. Scott, Gail Carson, Piero Olliaro, Louise Sigfrid, Charitini Stavropoulou
    medRxiv 2020.12.08.20246025; doi: https://doi.org/10.1101/2020.12.08.20246025
    Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools
    Characterising long term Covid-19: a living systematic review
    Melina Michelen, Vincent Cheng, Lakshmi Manoharan, Natalie Elkheir, Drew Dagens, Claire Hastie, Margaret O’Hara, Jake C. Suett, Dania T. Dahmash, Polina Bugaeva, Ishmeala Rigby, Daniel Munblit, Eli Harriss, Amanda Burls, Carol Foote, Janet T. Scott, Gail Carson, Piero Olliaro, Louise Sigfrid, Charitini Stavropoulou
    medRxiv 2020.12.08.20246025; doi: https://doi.org/10.1101/2020.12.08.20246025

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Public and Global Health
    Subject Areas
    All Articles
    • Addiction Medicine (240)
    • Allergy and Immunology (521)
    • Anesthesia (125)
    • Cardiovascular Medicine (1420)
    • Dentistry and Oral Medicine (217)
    • Dermatology (158)
    • Emergency Medicine (291)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (584)
    • Epidemiology (10297)
    • Forensic Medicine (6)
    • Gastroenterology (527)
    • Genetic and Genomic Medicine (2629)
    • Geriatric Medicine (254)
    • Health Economics (497)
    • Health Informatics (1733)
    • Health Policy (789)
    • Health Systems and Quality Improvement (673)
    • Hematology (266)
    • HIV/AIDS (565)
    • Infectious Diseases (except HIV/AIDS) (12093)
    • Intensive Care and Critical Care Medicine (649)
    • Medical Education (273)
    • Medical Ethics (83)
    • Nephrology (289)
    • Neurology (2461)
    • Nursing (145)
    • Nutrition (377)
    • Obstetrics and Gynecology (493)
    • Occupational and Environmental Health (568)
    • Oncology (1324)
    • Ophthalmology (401)
    • Orthopedics (146)
    • Otolaryngology (237)
    • Pain Medicine (168)
    • Palliative Medicine (51)
    • Pathology (343)
    • Pediatrics (780)
    • Pharmacology and Therapeutics (330)
    • Primary Care Research (296)
    • Psychiatry and Clinical Psychology (2397)
    • Public and Global Health (5007)
    • Radiology and Imaging (893)
    • Rehabilitation Medicine and Physical Therapy (528)
    • Respiratory Medicine (681)
    • Rheumatology (309)
    • Sexual and Reproductive Health (256)
    • Sports Medicine (245)
    • Surgery (298)
    • Toxicology (45)
    • Transplantation (140)
    • Urology (108)